| Term 
 | Definition 
 
        | Fatty acid derivatives of arachidonic acid - dilate arterioles, constrict pulmonary. Contract the uterus, responsible for gastric secretions, swelling, and edema. |  | 
        |  | 
        
        | Term 
 
        | What is the function of COX? |  | Definition 
 
        | Converts Arachidonic acid to PgG2 --> PgH2 --> end prostaglandins. O2 added to carbon 11 --> cyclization. Arachidonic acid is the substrate for Cox! NSAIDs mimic and block.
 |  | 
        |  | 
        
        | Term 
 
        | What are the main features of the COX active site? |  | Definition 
 
        | ARG residue is basic/positive = acidic active site. Forms an ionic bond Tyrosine - pi pi stacking
 Difference between Cox1 and Cox2 --> ILE --> Val makes a pocket
 |  | 
        |  | 
        
        | Term 
 
        | How does pKa and ionization affect ASA? |  | Definition 
 
        | If the pH is less than the pKa in an ACID, the compound will be unionized and unchanged. pH of the stomach is 2, and pKa of ASA is 3 = unchanged. In  the body, pH is higher --> ionizes as it crosses the cells of the stomach. In a base (NE), if pH is less than pKa, it is ionized.
 |  | 
        |  | 
        
        | Term 
 
        | How does ASA work on COX? |  | Definition 
 
        | ASA acetylates the serine residue irreversibly - COX inhibited in a platelet for than platelet's lifetime. Salicylic acid is left over --> non-covalently blocks COX
 |  | 
        |  | 
        
        | Term 
 
        | What is the SAR of COX? How is it gastricly toxic?
 |  | Definition 
 
        | Effects on COX1 and GI-effects are due to carboxylic acid. Has a pKa of 3, is unionized in the stomach. Crosses cells, becomes ionized at trapped. Inhibits cox, decreases mucous and blood flow --> increased permeability and less buffer made
 Dual insult - direct acid damage and PgE2 inhibition
 |  | 
        |  | 
        
        | Term 
 
        | How can the SAR of ASA be affected? |  | Definition 
 
        | If the carboxylic acid is changed to remove the hydroxy - more lipophilic and more toxic - Acetyl group is in the ortho position. Movement to -m or -p cannot bind to serine.
 - Addition at the 5 position adds AIF activity
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference between dolobid and ASA? |  | Definition 
 
        | No acetyl group - is reversible More electron-withdrawing = lipophilic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An ester bond is formed at the 5- position of ASA, and there is no acetyl. Cleavage gives 2 salacylic acids. |  | 
        |  | 
        
        | Term 
 
        | What is the general SAR of nonselective NSAIDs? |  | Definition 
 
        | Non-selective COX inhibitors have an acid center, usually adjacent to a ring. A methyl on this adjacent carbon increases activity - profens. |  | 
        |  | 
        
        | Term 
 
        | What is indomethacin and sulindac mimicing? |  | Definition 
 
        | Serotonin Need the carboxyl group, indole ring not necessary
 - Indomethacin - VERY potent but very toxic
 - Sulindac - prodrug, not active until the circulation thus less GI side effects. Fluoride = better analgesic
 - Z isomer =  better AIF
 |  | 
        |  | 
        
        | Term 
 
        | How is sulindac metabolized? |  | Definition 
 
        | Sulindac, a prodrug, gets reduced to become active. Must be the Z isomer to get reduced Active has a -S-CH2 group on the phenyl
 |  | 
        |  | 
        
        | Term 
 
        | What do Tolmentin/Etodolac/Diclofenac/Ketorolac have in common? |  | Definition 
 
        | They all have the acid core, and they all have a nitrogen, usually in a ring. Some have 2 rings. 
 All are derivatives of Indomethacin.
 |  | 
        |  | 
        
        | Term 
 
        | What kind of a structure is tolmetin? |  | Definition 
 
        | Similar to indomethacin, but has a pyrole (2 double bonds) instead of an indole). Strictly AIF |  | 
        |  | 
        
        | Term 
 
        | What kind of a structure is Ketorolac? |  | Definition 
 
        | Very similar to tolmetin, but has a fused ring. Only Analgesic activity. |  | 
        |  | 
        
        | Term 
 
        | What kind of a structure is Diclofenac? |  | Definition 
 
        | Like it's name, has 2 chloro's on the 2nd ring. Also inhibits LPO and arachidonic acid release. Rings are anti-planar |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A prostaglandin analog added to diclofenac (Arthrotec) to reduce GI upset and ulcers. Addition of a methyl at position 16 adds bioavailability. Causes diarrhea. |  | 
        |  | 
        
        | Term 
 
        | What is significant about Etodolac? |  | Definition 
 
        | Distance from indole to acid increased - less potent. May be preferential to cox 2, and far less gastric toxicity. Only the S is AIF. Acid at 1 and ethyl at 2 REQUIRED |  | 
        |  | 
        
        | Term 
 
        | What is the significance of Nabumetone's SAR? |  | Definition 
 
        | It is also a prodrug, and the prodrug is not an acid, reducing GI distress. Absorbs from the duodenum --> 6MNA metabolite. Oxidation of ketone to acid |  | 
        |  | 
        
        | Term 
 
        | What drugs are arylpropionic acids? |  | Definition 
 
        | -profens! Ibuprofen: Has chirality, S- isomer is active. However the R is inverted in vivo, thus both become active.
 Extensively ionized at a pKa of 4: excretion.
 Fenoprofen is weaker than Ibu, S is also active.
 Ketoprofen is very  lipophilic, good in muscle injuries
 Flurbiprofen has an extra aromatic ring
 Naproxen is racemic, more potent than Ibu. Same as 6MNA but has a methyl at 2-
 |  | 
        |  | 
        
        | Term 
 
        | Where is the acidity in Oxicams derived from? What is the general SAR?
 |  | Definition 
 
        | Longer half life, just as good as indomethacin. GI side effects. NO ACID CORE, comes from bronsted-lowry acidity. Has 2 R groups - both at the amines. Increased acidity increases pKa - due to enolate N. Hydrogen bonds move to form acid.
 - Mobic - Replace pyridine on piroxicam w/ methyl thiazolyl gives COX2 activity. Can be unionized at inflammation sites --> low gastric side effects
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference between COX1 and COX2? |  | Definition 
 
        | COX2 has a valine residue instead of ILE --> less bulky, provides a cleft. COX2 found in alzheimer's, colon cancer
 |  | 
        |  | 
        
        | Term 
 
        | What is the SAR of -coxibs? |  | Definition 
 
        | - non-acidic - PARA-sulfonamide group selective for pocket
 Metabolized by 2C9, inhibits 2D6. If a slow 2C9 metabolizer, can get toxic. 2D6 - SSRIs
 - Less GI, BUT can cause CV side effects.
 |  | 
        |  | 
        
        | Term 
 
        | What is the SAR of APAP? How does it work? |  | Definition 
 
        | Purely analgesic and antipyretic, can inhibit COX3 Basic at a pKa of 9.5. Metabolism by conjugation
 Still not sure of SAR!
 Children sulfate APAP, while adults use glutathione, which allows for renal excretion.
 |  | 
        |  | 
        
        | Term 
 
        | What are the 2 groups of steroids? |  | Definition 
 
        | - Glucocorticoids - regulate carbs, lipids, protein using ACTH and CRH - potent AIF. 4 rings with 2 methyls - Mineralocorticoids - regulate salt balance, have no AIF
 |  | 
        |  | 
        
        | Term 
 
        | What is steroid stereochemistry? How do they work?
 |  | Definition 
 
        | The delta is where the double bond is. Can be alcohols or ketones at the #3 position Specific for the glucocorticoid receptor --> AIF, immunosuppression. 3 step oxidation to pregnenolone
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference between hydrocortisone and cortisone? |  | Definition 
 
        | At the 11 position, cortisone has a ketone, and hydrocortisone has an alcohol. REQUIRED for GR, but not MR. C17-OH also gives GR activity. Hydrocortisone more orally bioavailable, but also more MR activity --> C21 -OH group grants MR activity. Remember feedback mechanism --> reason for tapering. |  | 
        |  | 
        
        | Term 
 
        | How does fludrocortisone compare to Cortisol? |  | Definition 
 
        | -9Falpha substitution, more potent GR activity BUT WAY more MR activity. Used for addison's disease. |  | 
        |  | 
        
        | Term 
 
        | How do prednisone and prenisolone compare to Cortisol? |  | Definition 
 
        | Addition of a C-C double bond between 1 and 2 increases GR and duration. Prednisone has a ketone at 11, while prenisolone has a -OH at 11 (like cortisol, higher GR activity). Boat conformation! |  | 
        |  | 
        
        | Term 
 
        | How does methylprednisolone compare to Cortisol? |  | Definition 
 
        | Addition of a methyl group at 6 increases GR activity while removing MR. |  | 
        |  | 
        
        | Term 
 
        | How does Triamcinolone compare to Cortisol? |  | Definition 
 
        | Addition of a -9F (like fludrocortisone), and also a -16OH, which adds AIF and lowers MR affinity. NOT orally bioavailable
 |  | 
        |  | 
        
        | Term 
 
        | How does dexamethasone compare to Cortisol? |  | Definition 
 
        | Used in cortisone shorts, a long acting steroid with high GR affinity, no MR affinity. Has the 1-2 double bond, the -9F, and a -16methyl which increases lipophilicity unlike the -16OH in triamcinolone |  | 
        |  | 
        
        | Term 
 
        | How does betamethasone compare to Cortisol? |  | Definition 
 
        | SAME structure as dexamethasone, but the -16methyl is a BETA (solid line) Less toxic, slightly more active.
 |  | 
        |  | 
        
        | Term 
 
        | How is uric acid reabsorbed? How does therapy work?
 |  | Definition 
 
        | renal tubular absorption weakly acidic with a pKa of 5.7. Therefore a decrease in pH leads to an increase in crystals. Therapy:
 - Inhibit Xanthine Oxidase
 - Reduce inflammation
 - Increase uric acid excretion
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An isomer of hypoxanthine, allopurinol competes for xanthine oxidase with a greater affinity --> inhibition and lower uric acid. Metabolite - oxypurinol has a longer half life, inhibits XO non-competitively.
 |  | 
        |  |